tabeleclusel

ebb vallo brand paerutoe vikrayinche tabeleclusel, epstein-baar virus positive post-transplant lymphoproliferative disease (ibivi + ptld) chikitsaku upayoginche aushadham. tabeleclusel anedi oka allogenic, ebv-nirdishta tii-sell immunotherapy, idhi maanava leukocyte antigen (hcla)-parimitam cheyabadina paddhatiloo ebv-sokina kanaalanu lakshyamgaa chesukuni tolagistundi. idhi graheeta (allogenic) nundi teesukunna tii-kanaalu anie piluvabade roganirodhaka vyavastha yokka kanaalatoe tayaaru cheyabadi, aapai adhe daata nundi ebivi-sokina bii-kanaalatoe kalapabadutundi.
atyanta saadhaarana dushprabhavalalo jwaram, atisaaram, alasata, vikaram (anaarogyamtho badhapadatam), raktaheenata (erra rakta kanaala takkuva sthaayilu), aakali taggadam, hyponetramia (takkuva rakta sodiyam sthaayilu), kadupu (kadupu) noppi, neutrophils (infectionlatho porade tella rakta kanaalu) thoo sahaa tella rakta kanaala takkuva sthaayilu, aspertate aminotransferase, alanine aminotransferase mariyu alkaleen phosphatase (kaaleya nashtam yokka sankethaalu), malabaddhakam, hypoxia (takkuva raktamlo oxygen sthaayilu), nirjaleekaranam, hypotension (takkuva raktapotu), nasika raddi mariyu daddurlu unnaayi.
european unionlo vaidya upayogam kosam 2022 decemberlo tabeleclusel aamodinchabadindi.
vaidya upayogaalu.
kaneesam oka mundastu chikitsanu pondina punaraavruta ledhaa vakreebhavana epstein-baar virus positive post-transplant lymphoproliferative disease (ebv + ptld) thoo rendu samvatsaraalu mariyu anthakante ekkuva vayassu unna vyaktula chikitsa kosam tabeleclusel monotherapyga suuchimchabadutumdi.
post-transplant lymphoproliferative desorder.
avayava marpidi cheyinchukunna vyaktulaku marpidi tiraskarananu nivaarinchadaaniki roganirodhaka saktini anachivese mandulatho mamuluga chikitsa chestaaru. chikitsa phalitamgaa, kontamandilo epstein-baar virus (ibivi) anubandha post-transplant lymphoproliferative desorder (ptld) abhivruddhi chendutundi, dheenilo tella rakta kanaalu ibivi baarina padataayi mariyu idhi aaa kanaala adhika vibajananu prerepistundi. ptld praarambhamlo cancer kaanidi, conny cancer hodgkin lymphomacu purogaminchavacchu. ptld yokka modati-varusa chikitsalalo retuximab vanti monoclonal antibodies mariyu cancer abhivruddhi chendinatlayithe chemotherapy unnaayi.
pratikuula prabhavalu.
atyanta saadhaarana dushprabhaavaalu jwaram, atisaaram, alasata, anaaroogyam, erra rakta kanaala takkuva sthaayi, aakali taggadam mariyu takkuva rakta sodiyam sthaayilu.
charitra.
ii. emm. yea. sifaarsu konasagutunna bahula kendra, dasha III, single-arm, open-label clinical trial phalitaalapai aadharapadi untundi. kaneesam oka mundastu chikitsanu pondina relapsed/refractory ebv + ptldtho 43 mandhi paalgonevaarilo tabeleclusel yokka samarthatha mariyu bhadratanu adhyayanam parisoedhimchimdi.
samajam mariyu samskruti.
chattaparamaina sthithi.
13 october 2022naa, european medicines agency (ii. emm. yea) yokka maanava upayogam kosam aushadha utpattula kamitee (chiech. emm. pii) oka saanukuula abhiprayanni sweekarinchindi, epstein-baar virus positive post-transplant lymphoproliferative disease (ibivi + ptld) chikitsa kosam uddesinchina aushadha utpatti ebballo kosam asaadhaarana paristhitulalo marketing adhikaranni manjuru cheyaalani sifaarasu chesindi. ebballo oka adhunaatana chikitsa aushadha utpatti kabatti, chp saanukuula abhiprayam adhunaatana chikitsala kosam kamitee anchanaapai aadharapadi untundi. eee aushadha utpattiki atara biotheraputics ireland limited darakhaastudaaru. european unionlo vaidya upayogam kosam 2022 decemberlo tabeleclusel aamodinchabadindi.

